These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11681019)

  • 1. [Immunohistochemical study of KL-6 in pulmonary tuberculosis].
    Inoue T; Ishida A; Yamamoto T; Seki R; Maruyama H; Noda T; Yashiro T; Tadokoro M
    Nihon Kokyuki Gakkai Zasshi; 2001 Aug; 39(8):553-8. PubMed ID: 11681019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis.
    Takahashi T; Munakata M; Suzuki I; Kawakami Y
    Am J Respir Crit Care Med; 1998 Oct; 158(4):1294-8. PubMed ID: 9769294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
    Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
    Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CA19-9-producing idiopathic pulmonary fibrosis with diffuse alveolar damage and a high titer of KL-6--an autopsy case].
    Shimizu Y; Tanaka Y; Sasaki A; Nemoto T
    Nihon Kokyuki Gakkai Zasshi; 2001 May; 39(5):351-6. PubMed ID: 11510099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical usefulness of KL-6 as a serum marker of idiopathic interstitial pneumonia].
    Kohno N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():186-9. PubMed ID: 9216213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].
    Sugimoto H; Okada E; Hashimoto N; Suzuki S; Yoshida H; Totani Y; Ameshima S; Ishizaki T; Miyamori I
    Rinsho Byori; 2000 Jun; 48(6):554-60. PubMed ID: 10897675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis.
    Bandoh S; Fujita J; Ohtsuki Y; Ueda Y; Hojo S; Tokuda M; Dobashi H; Kurata N; Yoshinouchi T; Kohno N; Takahara J
    Ann Rheum Dis; 2000 Apr; 59(4):257-62. PubMed ID: 10733471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of serum markers KL-6 and SP-D for interstitial pneumonia associated with connective tissue diseases].
    Suematsu E; Miyamura T; Shimada H; Nakao R; Yamamoto M
    Ryumachi; 2003 Feb; 43(1):11-8. PubMed ID: 12692985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of serum KL-6 levels in patients with pulmonary tuberculosis.
    Inoue Y; Nishimura K; Shiode M; Akutsu H; Hamada H; Fujioka S; Fujino S; Yokoyama A; Kohno N; Hiwada K
    Tuber Lung Dis; 1995 Jun; 76(3):230-3. PubMed ID: 7548906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases.
    Nakajima H; Harigai M; Hara M; Hakoda M; Tokuda H; Sakai F; Kamatani N; Kashiwazaki S
    J Rheumatol; 2000 May; 27(5):1164-70. PubMed ID: 10813282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of serum KL-6 levels in summer-type hypersensitivity pneumonitis].
    Nakajima M; Toshiaki M; Yoshida K; Niki Y; Matsushima T
    Nihon Kokyuki Gakkai Zasshi; 1998 Sep; 36(9):763-70. PubMed ID: 9866978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of the the ED046 kit to analyze serum KL-6 in patients with pneumonitis].
    Kitamura S; Hiwada K; Kobayashi J; Kohno N; Kawai T; Satou A; Kasukawa R; Kawakami Y; Andou M; Nakada G; Inoue H; Itou K; Matsushima T; Ogura T; Arakawa M; Yamakido M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jun; 34(6):639-45. PubMed ID: 8741528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases.
    Ohnishi H; Yokoyama A; Kondo K; Hamada H; Abe M; Nishimura K; Hiwada K; Kohno N
    Am J Respir Crit Care Med; 2002 Feb; 165(3):378-81. PubMed ID: 11818324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of serum KL-6 in pulmonary sarcoidosis].
    Kondo R; Horiguchi T; Teruya S; Banno K; Ishibashi A; Sasaki Y; Handa M; Tachikawa S
    Nihon Kokyuki Gakkai Zasshi; 2001 Nov; 39(11):823-8. PubMed ID: 11855079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment of reference intervals and cut-off value by an enzyme immunoassay for KL-6 antigen, a new marker for interstitial pneumonia].
    Kobayashi J; Itoh Y; Kitamura S; Kawai T
    Rinsho Byori; 1996 Jul; 44(7):653-8. PubMed ID: 8801361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of serum Krebs von den Lunge-6 levels in patients with tubulointerstitial nephritis and uveitis syndrome.
    Kase S; Kitaichi N; Namba K; Miyazaki A; Yoshida K; Ishikura K; Ikeda M; Nakashima T; Ohno S
    Am J Kidney Dis; 2006 Dec; 48(6):935-41. PubMed ID: 17162148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KL-6 as an indicator for lymphocytic interstitial pneumonia (LIP) in a human T-lymphotrophic virus type 1 (HTLV-1) carrier.
    Ishikawa N; Awaya Y; Maeda H; Miyazaki M; Fujitaka K; Yamasaki M; Kondo K; Oguri T; Isobe T; Kohno N
    Ann Hematol; 2002 Aug; 81(8):474-7. PubMed ID: 12224007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis.
    Kohno N
    J Med Invest; 1999 Aug; 46(3-4):151-8. PubMed ID: 10687309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
    Yamane K; Ihn H; Kubo M; Yazawa N; Kikuchi K; Soma Y; Tamaki K
    J Rheumatol; 2000 Apr; 27(4):930-4. PubMed ID: 10782818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of serum KL-6 in diagnosis of interstitial pneumonia complicated with collagen disease].
    Harigai M
    Nihon Naika Gakkai Zasshi; 2003 Oct; 92(10):1985-9. PubMed ID: 14621589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.